Диссертация (1141195), страница 22
Текст из файла (страница 22)
2004. Vol. 26(6). P. 679684.232. Owen A., Goldring C., Morgan P., Chadwick D., Park B.K., Pirmohamed M.Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1gene and P-glycoprotein expression in human liver.// Br. J. Clin. Pharmacol. 2005.Vol.
59(3). P. 365-370.233. Ozawa S, Soyama A, Saeki M, Fukushima-Uesaka H, Itoda M, Koyano S, SaiK, Ohno Y, Saito Y, Sawada J. Ethnic differences in genetic polymorphisms ofCYP2D6,CYP2C19,CYP3AsandMDR1/ABCB1.DrugMetabPharmacokinet. 2004;19:83–95234. Pallis M, Turzanski J, Grundy M, Seedhouse C, Russell N. Resistance tospontaneous apoptosis in acute myeloid leukaemia blasts is associated with pglycoprotein expression and function, but not with the presence of FLT3 internaltandem duplications.
Br J Haematol. 2003 Mar;120(6):1009-16.235. Park H.J., Shinn H.K., Ryu S.H., Lee H.S., Park C.S., Kang J.H. Geneticpolymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans.// ClinPharmacol Ther. 2007. Vol. 81(4). P. 539-546.236. Park JY, Kim KA, Lee GS, Park PW, Kim SL, Lee YS, Lee YW, Shin EK.Randomized, open-label, two-period crossover comparison of the pharmacokineticand pharmacodynamic properties of two amlodipine formulations in healthy adultmale Korean subjects.
Clin Ther. 2004;26:715–23153237. Parker RB, Yates CR, Laizure SC, Weber KT. P-glycoprotein modulatesaldosterone plasma disposition and tissue uptake. J Cardiovasc Pharmacol. 2006Jan;47(1):55-9. ]238. Patak P, Jin F, Schäfer ST, Metzen E, Hermann DM. The ATP-bindingcassette transporters ABCB1 and ABCC1 are not regulated by hypoxia inimmortalised human brain microvascular endothelial cells.ExpTranslStrokeMed.2011 Oct 26;3:12.239. Patel VA, Dunn MJ, Sorokin A.Regulation of MDR-1 (P-glycoprotein) bycyclooxygenase-2.JBiolChem. 2002 Oct 11;277(41):38915-20.240.
Paulussen иcoaвт. (2000): (Nebert D.W., Adesnik M., Coon M.J. et al. TheP450 gene superfamily: recommended nomenclature // DNA. - 1987. - Vol. 6 - P. 111241. Pawlik A, Baskiewicz-Masiuk M, Machalinski B, Gawronska-Szklarz B.Involvement of P-gp in the process of apoptosis in peripheral blood mononuclearcells. Int Immunopharmacol.
2005 May;5(5):821-8. Epub 2005 Jan 21.242. Peters BJ, Rodin AS, Klungel OH, van Duijn CM, Stricker BH, van't Slot R,de Boer A, Maitland-van der Zee AH. Pharmacogenetic interactions betweenABCB1 and SLCO1B1 tagging SNPs and the effectiveness of statins in theprevention of myocardial infarction. Pharmacogenomics. 2010 Aug;11(8):1065-76.Source:FacultyofScience,DivisionofPharmacoepidemiology&Pharmacotherapy, Utrecht University, Utrecht, The Netherlands.243. Philipp T, Smith TR, Glazer R, et al.
Two multicenter, 8-week, randomized,double-blind, placebo-controlled, parallel-group studies evaluating the efficacy andtolerability of amlodipine and valsartan in combination and as monotherapy in adultpatients with mild to moderate essential hypertension.
Clin Ther.2007;29:563–580.doi: 10.1016/j.clinthera.2007.03.018154244. Rosenberg MF, Callaghan R, Ford RC, Higgins CF. Structure of the multidrugresistance P-glycoprotein to 2.5 nm resolution determined by electron microscopyand image analysis. J Biol Chem. 1997 Apr 18;272(16):10685-94. ]245. S. Miller, Björn Bauer, and Anika M.S.
Hartz Modulation of P- glycoproteinat the Blood-Brain Barrier: Opportunities to Improve CNS Pharmacotherapy.PharmacolRev. 2008 June; 60(2): 196–209.David246. Sabahi Z, Salek R, Heravi RE, Mosaffa F, Avanaki ZJ, Behravan J.Association of gastric cancer incidence with MDR1 gene polymorphism in an ethnicIranian population. Indian J Cancer. 2010Jul-Sep;47(3):317-21.) 247. Safford MM, et al. Understanding racial disparities in hypertension control:intensity of hypertension medication treatment in the REGARDS study. EthnDis.
2007;17:421–426.248. Sakaeda T. MDR1 genotype-related pharmacokinetics: fact or fiction? DrugMetab Pharmacokinet. 2005 Dec;20(6):391-414. 249. Seelig A, Landwojtowicz E.Structure-activity relationship of P-glycoproteinsubstrates and modifiers.EurJPharmSci.2000 Nov;12(1):31-40. 250. Seigneuret M, Garnier-Suillerot A. A structural model for the openconformation of the mdr1 P-glycoprotein based on the MsbA crystal structure. J BiolChem. 2003 Aug 8;278(32):30115-24.
Epub 2003 May 30. ]251. Seo T, Ishitsu T, Ueda N, Nakada N, Yurube K, Ueda K, Nakagawa K.ABCB1 polymorphisms influence the response to antiepileptic drugs in Japaneseepilepsy patients. Pharmacogenomics. 2006 Jun;7(4):551-61.252. Siegmund W, Ludwig K, Giessmann T, Dazert P, Schroeder E, Sperker B,Warzok R, Kroemer HK, Cascorbi I. The effects of the human MDR1 genotype onthe expression of duodenal P-glycoprotein and disposition of the probe drugtalinolol. Clin Pharmacol Ther. 2002 Nov;72(5):572-83.155253.
Sills GJ, Mohanraj R, Butler E, McCrindle S, Collier L, Wilson EA, BrodieMJ. Lack of association between the C3435T polymorphism in the human multidrugresistance (MDR1) gene and response to antiepileptic drug treatment. Epilepsia.2005 May;46(5):643-7.254. Singh D, Alexander J, Owen A, Rustom R, Bone M, Hammad A, Roberts N,Park K, Pirmohamed M. Whole-blood cultures from renal-transplant patientsstimulated ex vivo show that the effects of cyclosporine on lymphocyte proliferationare related to P-glycoprotein expression.
Transplantation. 2004 Feb 27;77(4):55761.255. Smyth MJ, Krasovskis E, Sutton VR, Johnstone RW. The drug efflux protein,P-glycoprotein, additionally protects drug-resistant tumor cells from multiple formsof caspase-dependent apoptosis. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):70249.256.
Spiewak M, Małek ŁA, Kostrzewa G, Kisiel B, Serafin A, Filipiak KJ, PłoskiR, Opolski G. Influence of C3435T multidrug resistance gene-1 (MDR- 1)polymorphism on platelet reactivity and prognosis in patients with acute coronarysyndromes. Kardiol Pol. 2009 Aug;67(8):827-34. 257. Sugawara I, Akiyama S, Scheper RJ, Itoyama S. Lung resistance protein(LRP) expression in human normal tissues in comparison with that of MDR1 andMRP. Cancer Lett. 1997 Jan 15;112(1):23258. Sun M, Kingdom J, Baczyk D, Lye SJ, Matthews SG, Gibb W. Expression ofthe multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the humanplacenta decreases with advancing gestation.
Placenta. 2006 Jun- Jul;27(6-7):602-9.Epub 2005 Sep 6.259. Synold TW, Dussault I, Forman BM. The orphan nuclear receptor SXRcoordinately regulates drug metabolism and efflux.Nat Med. 2001 May;7(5):58490.156260. Takara K, Kakumoto M, Tanigawara Y, Funakoshi J, Sakaeda T, OkumuraK.Interaction of digoxin with antihypertensive drugs via MDR1.Life Sci.2002 Feb15;70(13):1491-500.261. Takara K, Sakaeda T, Kakumoto M, Tanigawara Y, Kobayashi H, OkumuraK, Ohnishi N, Yokoyama T. Effects of alpha-adrenoceptor antagonist doxazosin onMDR1-mediated multidrug resistance and transcellular transport. Oncol Res.2009;17(11-12):527-33262.
Taubert D, von Beckerath N, Grimberg G, Lazar A, Jung N, Goeser T,Kastrati A, Schömig A, Schömig E. Impact of P-glycoprotein on clopidogrelabsorption. Clin Pharmacol Ther. 2006 Nov;80(5):486-501.263. Terao T, Hisanaga E, Sai Y, Tamai I, Tsuji A.
Active secretion of drugs fromthe small intestinal epithelium in rats by P-glycoprotein functioning as an absorptionbarrier. J Pharm Pharmacol. 1996 Oct;48(10):1083-9264. Tessner TG, Stenson WF. Overexpression of MDR1 in an intestinal cell lineresults in increased cholesterol uptake from micelles. Biochem Biophys ResCommun. 2000 Jan 19;267(2):565-71.265. Thévenod F, Friedmann JM, Katsen AD, Hauser IA. Up-regulation ofmultidrug resistance P-glycoprotein via nuclear factor-kappaB activation protectskidney proximal tubule cells from cadmium- and reactive oxygen species-inducedapoptosis.JBiolChem. 2000 Jan 21;275(3):1887-96.266.
Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC.Cellular localization of the multidrug-resistance gene product P- glycoprotein innormal human tissues. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7735-8.267. Thomson A. Why do therapeutic drug monitoring. The Pharm. Journal 2004:273:153-155268. Thörn M, Finnström N, Lundgren S, Rane A, Lööf L. Cytochromes P450 andMDR1 mRNA expression along the human gastrointestinal tract. Br J Clin157Pharmacol.
2005 Jul;60(1):54-60. (66 ) (Fromm MF. Importance of P- glycoproteinat blood-tissue barriers. Trends Pharmacol Sci. 2004 Aug;25(8):423-9. ]269. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T,Hori R. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone,but not progesterone. J Biol Chem. 1992 Dec 5;267(34):24248-52.270. Uhr M, Holsboer F, Müller MB. Penetration of endogenous steroid hormonescorticosterone, cortisol, aldosterone and progesterone into the brain is enhanced inmice deficient for both mdr1a and mdr1b P-glycoproteins.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
